Glucose is an essential fuel for cell survival and its availability limits aberrant cellular proliferation. We have hypothesized that specific cancer mutations regulate metabolic response(s) to glucose deprivation (GD). By means of somatic knock-in cellular models, we have analyzed the response to glucose deprivation in cells carrying the frequent delE746-A750 EGFR, G13D KRAS or E545K PIK3CA cancer alleles. We demonstrate that, in mammary epithelial cells, glucose has an essential antioxidant function and that these cells are very sensitive to GD. Conversely, isogenic cells carrying the delE746-A750 EGFR or the E545K PIK3CA, but not the G13D KRAS allele, display high tolerance to GD by stimulating the expression of anti-oxidant genes (MnSOD and catalase). This adaptive transcriptional response is mediated by the activation of WNT/b-catenin and FOXO4 signalling. Our data highlights a new functional synergism between oncogenic EGFR and PIK3CA with WNT/bcatenin conferring high tolerance to oxidative stress generated by nutrient deprivation. 
Introduction
Glucose is a fundamental cellular fuel for the generation of ATP and NADH through glycolysis and the mitochondrial oxidative phosphorylation; it is also an essential component of the pentose phosphate shunt pathway (PPP) that leads to the production of NADPH used to synthesize reduced glutathione, a potent intracellular antioxidant. Thus, glucose deficit is likely to produce energetic dysfunction and oxidative stress.
Glucose limitation is a common stress during tumor progression: glucose concentration acts as an energetic barrier against the aberrant cellular proliferation of pre-malignant cells [1] ; moreover, an energetic deficit occurs in certain areas of solid tumors where glucose and oxygen deficiencies are generated by the unstable tumor microenvironment or ischemia [1] , [2] . Thus, cellular adaptation to sub-optimal nutrients concentrations appears as a relevant phenotype that cancer cells acquire during tumor progression. A key open issue is to identify the specific genetic alteration(s) that drive the metabolic adaptation of cancer cells to glucose deficiency. Recently, the G13D KRAS and V600E B-Raf oncogenes have been associated with a resistance to low glucose and G13D KRAS mutations occur in cells upon selection in low glucose environment [3] . In addition, tumors carrying deletions of the tumor suppressor PTEN, a lipid phosphatase, are resistant to caloric restriction in vivo [4] .
Epidermal Growth Factor Receptor (EGFR) and the phosphatidylinositol 3-kinase (PI3K), are oncogenes frequently mutated in human cancers. PI3Ks are a family of lipid kinases that phosphorylate the 3-OH group on phosphatidylinositols in the plasma membrane. This leads to the recruitment to the cell membrane and activation of the protein Ser/Thr-kinase AKT. The PI3K/AKT signaling cascade is critical in cancer development since it controls the activity of fundamental cell fate regulators and promotes cell survival and growth. Activating mutations in PIK3CA, the gene encoding the p110a catalytic subunit or inactivating mutations of PTEN, have been identified in a variety of solid tumors [5] , [6] , including colorectal, breast and endometrial cancers. Notably, three recurrent oncogenic ''hotspot'' mutations include the majority of somatic PIK3CA mutations. Two of these mutations, the E542K and the E545K, occur in the helical domain, and the third mutation, H1047R, affects the kinase domain [7] . All three mutations result in enhanced lipid kinase activity.
EGFR is a receptor tyrosine kinase involved in the control of DNA synthesis, cell proliferation, migration and adhesion [8] . Upon binding with extracellular ligands and dimerization, EGFR leads to the activation of multiple intracellular signaling pathways, such as the PI3K/AKT, the MEK/ERK and the JAK/STAT pathways. EGFR overexpression by gene amplification or by EGFR activation have been associated with several cancers, including lung and breast cancer and glioblastoma multiforme [9] , [10] . A specific point mutation L858R-and short in-frame deletions in exon 19 account for approximately 90% of the mutated cases [11] . The in frame deletion E746-A750 in exon 19 induces a ligand independent EGFR dimerization and activation [12] .
To date, we have limited information about the interference of the specific cancer mutations of EGFR and PIK3CA with metabolic responses of cells exposed to glucose deprivation. To gather information on this issue, we have investigated the cellular response to glucose deprivation (GD) in cells carrying the delE746-A750 EGFR, the E545K PIK3CA or the G13D KRAS mutations. For these studies, we have implemented a panel of isogenic cell lines generated by targeted homologous recombination to introduce (knock-in) a cancer allele in the genome of human somatic cells [13] . The derivative cells express the cancer alleles under the control of their endogenous promoter, thus allowing the study of the mutated proteins under physiological conditions relative to the expression levels and transcriptional regulation.
Our studies reveal that, in mammary epithelial cells, GD induces a drop in the ATP content, a significant reduction of the cellular antioxidant power resulting in oxidative stress and ultimately, cell death. In contrast, isogenic cells carrying
PIK3CA alleles, upon GD, engage antioxidant strategies, by increasing the expression of MnSOD and catalase genes that attenuate the oxidative stress. The activation of such adaptive transcriptional response is mediated by WNT signals through the action of b-catenin and FOXO4 transcription factors.
Results
The delE746-A750 EGFR and the E545K PIK3CA cancer alleles confer resistance to GD
We implemented a panel of isogenic cells generated by targeted homologous recombination (Knock-in) of delE746-A750 EGFR,
E545K
PIK3CA or G13D KRAS cancer alleles in immortalized human mammary epithelial cells (HME) [13] . The expression of cancer alleles affects the regulation of downstream signaling pathways as confirmed by serum deprivation experiments ( Figure S1 ): in fact, serum starvation elicited a dose-dependent reduction of phosphorylation of AKT(Ser473), of EGFR(Tyr1068), and ERK1/ 2(Thr202/Tyr204) in wild type HME cells, while isogenic clones, expressing the oncogenes, did not specifically reduce the phosphorylation of the same substrates ( Figure S1 ).
We then investigated cell survival in response to GD of wild type and the isogenic lines expressing the mutant alleles. Prolonged GD affects cell cycle and cell viability [14, 15] . FACS analysis revealed that GD induced cell death in wild type cells, while isogenic clones expressing the E545K PIK3CA or the delE746-A750 EGFR mutated proteins were resistant to GD. In contrast, the presence of G13D KRAS allele specifically led to higher sensitivity to GD (Figure 1) . Similar results were observed in independently generated isogenic HME clones ( Figure S2 ). To rule out that the observed differences in cell viability between wild type cells and the isogenic derivatives were an artefact due to the procedures used to generate the cellular model, we analyzed isogenic HME cells generated through the homologous recombination of the wild type alleles of EGFR or PIK3CA genes, here referred to as PIK3CA_cnt and EGFR_cnt. GD induced cell death of these control cells as well as in wild type HME cells ( Figure S2 ). These data indicate that resistance to GD-induced death is specifically conferred by the activating delE746-A750 EGFR or E545K PIK3CA mutations.
The oncogenic variants control ATP levels and GSH/GSSG ratio in response to GD Glucose is a fundamental cellular energy supply for ATP production. Moreover, glucose also fuels the pentose phosphate pathway (PPP), the metabolic process that stimulates the anabolism and generates cellular NADPH and supports the production of reduced glutathione (GSH), the most important cellular antioxidant. Thus, GD is expected to induce both energetic and oxidative stress. To evaluate the metabolic effects elicited by GD in HME wild type and isogenic clones, we measured total ATP content and the ratio between reduced and oxidized glutathione (GSH/GSSG ratio) following GD. Time course analysis revealed that wild type HME and isogenic clones carrying G13D KRAS or E545K PIK3CA oncogenes displayed a significant time-dependent reduction of the ATP levels following GD; in contrast, isogenic clones carrying the delE746-A750 EGFR retained 100% of ATP content up to 10 hours after treatment (Figure 2A) . Moreover, GD induced a significant reduction of the GSH/GSSG ratio in wild type HME cells, in G13D KRAS-carrying cells and in isogenic control cells but NOT in clones carrying delE746-A750 EGFR and
PIK3CA alleles ( Figure 2B ). These data show that glucose is essential in mammary epithelial cells to maintain redox homeostasis and that some oncogenic mutations specifically compensate redox unbalance induced by glucose deprivation
GD induces cell death through oxidative stress
The results in Figure 2 indicated that, in wild type cells, GD elicited a drop of the intracellular GSH/GSSG ratio that reduced the intracellular antioxidant power and induced a redox stress. To analyze the relevance of the oxidative stress generated by GD, we measured the effects of antioxidants on GD-induced cell death. Pre-treatment of wild type HME cells with N-Acetyl-L-Cysteine, which increases the GSH pool and enhances ROS scavenging, prevents cell death induced by GD ( Figure 3A) . Notably, under the same conditions, pre-treatment of the cells with sodium pyruvate, did not affect GD-induced cell death, indicating that the energetic stress, resulting from ATP drop, was indeed not the major driver of GD-induced cell death ( Figure 3A) . As NAC contributes also to H 2 0 2 -scavenging by increasing the GSH intracellular pool, we assessed the relevance of H 2 0 2 concentration in GD-induced cell death. Our data show that treatment with purified human catalase, an H 2 0 2 -scavenger enzyme, inhibited GD-induced cell death in wild type HME cells ( Figure 3B ). Taken together, these data indicate that glucose has an essential antioxidant role in mammary epithelial cells.
AMPKa is a sensor of GD-induced oxidative stress
The AMP-activated protein kinase (AMPK) is a key molecular sensor and regulator of the cellular response to glucose deprivation [16, 17] . To further understand to what extent glucose deprivation elicits a metabolic stress in wild type HME and in isogenic clones carrying oncogenes, we studied the activation of AMPKa by measuring the phosphorylation of AMPKa(T172), a specific marker of kinase activation [16, 17] . Our data show that AMPKa(T172) was highly phosphorylated upon 10 hours of GD in wild type cells and G13D KRAS expressing cells, whereas this phosphorylation was attenuated in isogenic HME cells carrying the E545K PIK3CA or the delE746-A750 EGFR cancer alleles (Fig. 4A) . Similar results were observed in independently generated isogenic HME clones ( Figure S3A ). Moreover, the observed attenuation was specifically induced by the oncogenes, since control cells displayed a robust activation of AMPKa(T172) phosphorylation after GD treatment ( Figure S3B ). The attenuation of AMPKa phosphorylation by cancer alleles was further confirmed by time course analysis of AMPKa(T172) phosphorylation after GD ( Figure 4B ).
AMPK is a general stress sensor that can be activated by AMP or by multiple intracellular signals such as calcium [18] , free fatty acids [19] and reactive oxygen species (ROS) [20] . To link the oxidative stress induced by GD to AMPK activation, we pretreated wild type HME cells before GD with the antioxidant NAC and we analyzed the AMPKa(T172) phosphorylation. Immunoblot analysis of protein extracts shows that NAC attenuated GDinduced phosphorylation of AMPK ( Figure 4C ). Similar results were obtained by pre-treating the cells with a SOD mimetic compound that is able to neutralize cellular superoxide ( Figure 4D ). Finally, pre-treatment of wild type HME cells with purified human catalase reduced also GD-induced AMPK phosphorylation ( Figure 4E ). The antioxidant activity of glucose is dependent on its ability to stimulate G6PDH activity and to support the PPP: in fact, the inhibition of G6PDH by the specific inhibitor 6-aminonicotinamide (6AN) was sufficient to induce oxidative stress and to phosphorylate AMPK in the presence of glucose. 6AN-induced AMPKa phosphorylation was controlled by ROS since it was inhibited by the pre-treatment of cells with NAC ( Figure 4F ). These data show that GD induces a significant oxidative stress that contributes to AMPK phosphorylation. In cells carrying activated oncogenes, this circuitry is not efficient. It is possible that the oxidative stress is attenuated in these cells, as suggested by Figure 2 . However, it is also likely that AMPK is inhibited by oncogenic ERK-dependent signals through increased phosphorylation of the major AMPK activating kinase, LKB1, which, when phosphorylated at Serine 428, inhibits AMPK [21, 22] . To discriminate between these two possibilities we measured the phosphorylation of LKB1(S428) after GD in wild type HME and isogenic clones.
Western blot analysis showed that LKB1 levels were comparable in wild type HME and in isogenic clones ( Figure 5A ). GD induced a reduction of total LKB1 protein both in wild type and isogenic cells carrying E545K PIK3CA or delE746-A750 EGFR alleles. By using specific antibodies against phospho-Ser428LKB1, we found that GD reduced phospho-LKB1(S428) levels in wild type HME cells as well as in isogenic clones ( Figure 5A ). Moreover, the treatment with AICAR, an AMP analogue, efficiently induced AMPKa(T172) phosphorylation in wild type HME cells as well as in isogenic clones carrying the delE746-A750 EGFR and E545K PIK3CA alleles ( Figure 5B ). Importantly, AICAR treatment, in contrast to GD, did not downregulate LKB1 and phospho-LKB1(S428) levels ( Figure 5B ), supporting the hypothesis that other mechanisms, in addition to the AMP/ATP ratio, control the LKB1/AMPK complex after exposure to GD. Collectively, these data demonstrate that mammary epithelial cells expressing the delE746-A750 EGFR and the E545K PIK3CA oncogenes have a functional AMP/LKB1/AMPKa sensor circuitry and that the attenuation of AMPK activation depends on the control of oxidative homeostasis.
delE746-A750 EGFR and E545K PIK3CA oncogenes specifically induce antioxidant enzymes in response to GD A simple mechanism explaining the resistance of oncogenecarrying cells to GD is the production of endogenous glucose, for example from glycogen storage. Determination of total glycogen levels indicated that HME cells carrying the delE746-A750 EGFR and E545K PIK3CA alleles contain higher total glycogen compared to isogenic wild type or control HME ( Figure 6 ). Notably, 309 after GD, we observed a rapid and strong decrease of glycogen content in both control and oncogene-carrying cells; after 30 minutes of GD, glycogen content declined in all cell lines, although steeper in oncogene-carrying cells than controls. Also, the pharmacological inhibition of glycogenolysis with a glycogen phosphorylase inhibitor (CP91149) did not significantly affect the viability of oncogene-carrying cells after GD (data not shown). These data indicate that glycogen storage was not responsible for the resistance to GD of oncogene-carrying cells.
We next tested the possibility that resistance to GD may depend on antioxidant strategies. An efficient antioxidant response relies on the rapid changes of expression of antioxidant enzymes. To this end we analyzed the expression of relevant antioxidant genes. Quantitative real time-PCR analysis revealed that HME cells expressing the delE746-A750 EGFR or
E545K
PIK3CA alleles showed a two fold increase of Manganese Superoxide dismutase (MnSOD) mRNA compared to wild type cells ( Figure 7A ). Moreover, HME clones expressing selectively EGFR and PIK3CA oncogenes displayed a robust expression of Manganese Superoxide dismutase (MnSOD) and catalase mRNAs following GD ( Figure 7B ). On the other hand,
G13D
KRAS-expressing cells did not stimulate the expression of these antioxidant genes ( Figure 7B ). Western blot analysis on total protein extracts confirmed that oncogene-carrying clones have significant higher levels of MnSOD protein compared to wild type cells ( Figure S4 ). . ATP content and GSH/GSSG ratio in wild type or oncogene-expressing HME cells after glucose deprivation. (A) Total ATP content after GD in wild type HME cells and isogenic clones carrying delE746-A750 EGFR, E545K PIK3CA or G13D KRAS cancer alleles. At the indicated time, cells were harvested and the total ATP content was analyzed; ATP amount was normalized for the number of nuclei. Results (mean 6 SD, n = 3) are expressed as percentages of the ATP amount respect to T = 0. WTp: wild type HME parental cells; PI3K_cnt and EGFRdel_cnt are HME control cells carrying the wild type alleles obtained through somatic homologous recombination (see text for details). (B) Reduced and oxidized glutathione ratio (GSH/GSSG) in wild type, control and oncogenes-carrying cells after GD. Cells were glucose starved for 10 hours, and then the GSH/GSSG ratio was measured. Results report the average of eight independent experiments 6 SD (t-test, **p,0.01, Not treated Vs GD-treated cells. ns: not significant). doi:10.1371/journal.pone.0037526.g002
b-catenin and FOXO4 are involved in the oncogenesdriven responses to GD To find the specific transcriptional network induced by the oncogenes following GD, we have searched for transcription factors that stimulate Catalase and MnSOD gene expression. These genes are known targets of the Forkhead transcription factors (FOXOs) [23, 24] and b-catenin, a key effector of the WNT pathway [25, 26] . Although the PI3K/AKT-dependent signaling has been recognized as a negative regulator of FOXOs, FOXO4 and b-catenin proteins can accumulate into nucleus and act as transcriptional sensors of oxidative stress independently of the presence of growth factors [26, 27] . Based on these observations, we studied the regulation of b -catenin and FOXO4 after GD in wild type HME cells and in isogenic clones carrying oncogenes. Since stability and nuclear localization of b-catenin are negatively controlled by a GSK3b kinase-dependent phosphorylation of Ser33,37 and Thr41 residues of b-catenin, we assayed the phosphorylation of these residues in response to GD. Western blot with specific antibodies indicated that phosphorylation of the Ser33,37 and Thr41 of b-catenin was rapidly inhibited in response to GD in oncogenes-carrying cells but not in wild type cells ( Figure 8A and 8B). Ser33,37 and Thr41 phosphorylation of bcatenin in wild type cells under GD was mainly dependent on GSK3b kinase activity since exposure to the GSK3b inhibitor, lithium chloride, eliminated the phosphorylation of these residues of b-catenin ( Figure 8A ). These data suggest that oncogenic EGFR and PI3K selectively inhibit GSK3b during GD. Accordingly, immunoblot analysis showed that the levels of phosphorylated GSK3b(S9), an inhibitory site phosphorylated by AKT, was higher in oncogene-expressing cells exposed to GD ( Figure 8C ).
Since active b-catenin is targeted to the nucleus, we monitored b-catenin nuclear accumulation in response to GD. Our data show that HME cells carrying-oncogenes accumulate significant nuclear b-catenin in response to GD compared to isogenic wild type cells ( Figure 8D ). To further document the activation of b-catenin, we performed immmunoflorescence analysis by using specific antibodies recognizing active, not-phosphorylated, b-catenin. Our data indicate that nuclear localization of active b-catenin is increased in HME cells expressing the delE746-A750 EGFR or the E545K PIK3CA alleles compared to the isogenic wild type cells; after exposure to GD, active b-catenin robustly accumulate into nucleus of oncogenes-carring cells, more efficiently than wild type cells. These data demonstrate that the delE746-A750 EGFR and the E545K PIK3CA proteins stimulate b-catenin activation and targeting to the nucleus following exposure to glucose deprivation ( Figure 8E ). We next analyzed the expression of FOXO4: western blot analysis demonstrated that oncogenes-carrying cells displayed a 2-fold increase of nuclear FOXO4 compared to wild type cells, independently of GD ( Figure 8D) ; this effect was specific to FOXO4, since nuclear FOXO1 was indeed reduced in cells carrying activated EGFR and PI3K pathways ( Figure 8D ). However, we observed a reduction of nuclear FOXO1 in response to GD in wild type cells but not in isogenic clones carrying oncogenes, suggesting that oncogenic EGFR and PIK3CA also stabilized FOXO1 in response to GD ( Figure 8D ).
To further investigate whether FOXO4 and b-catenin cooperate to activate the expression of antioxidant genes in response to GD in HME cells, we used a MnSOD promoter reporter assay previously described [25, 26] . b-catenin was able to enhance FOXO4-dependent and independent transcription of the MnSOD promoter in wild type HME cells under GD ( Figure 8F , left graph), indicating that MnSOD promoter can be also activated by stimuli FOXO4-independent, but b-catenin-dependent ( Figure 8F , left graph). As expected, MnSOD promoter reporter assay was significantly stimulated in HME cells carrying the delE746-A750 EGFR or the E545K PIK3CA oncogenes compared to wild type cells ( Figure 8F, right graph) . The GSK3b/FOXO4/MnSOD axis enhances the survival of mammary epithelial cells exposed to GD To functionally link the GSK3b and b-catenin axis with the response to glucose deprivation, we co-expressed b-catenin and FOXO4 in wild type HME cells and monitored cell death after 48 hours of exposure to GD. Our data demonstrate that the expression of b-catenin and FOXO4 improves resistance to GD of wild type HME cells ( Figure 9A ). Moreover, we also demonstrate that the expression of the GSK3b(K85A) mutant -a GSK3b kinase dominant negative -protects wild type cells from GDinduced death ( Figure 9A ). Expressing wild type GSK3b kinase did not induce the protective effect. These data underline the importance of the constitutive, oncogenic activation of EGFR/ G13D KRAS: dark gray square. Data are representative of three independent experiments that gave similar results. (C and D) Treatment with antioxidants attenuates GD-induced pAMPKa(T172). Wild type HME cells were pre-treated with N-acetyl-L-Cysteine (C) or mimetic SOD (D) 1 hour before glucose starvation. Proteins extracts were analyzed by immunoblot with anti-pAMPKa(T172) and anti-AMPKa antibodies. The graph reports the densitometry analysis of the pAMPKa/AMPKa total ; average from at least three independent experiments 6 SD are reported as relative fold to not-treated cells. (E) Catalase treatment reduces GD-induced pAMPKa. Wild type HME cells were treated with catalase at the indicated concentrations and harvested after 3 hours of GD. Equal amount of protein lysates were analyzed by immunoblot. (F) G6PDH inhibitor induces AMPKa(T172) phosphorylation through ROS generation. Wild type HME cells were treated as indicated with 6-AN in glucose-and serum-containing media (left panels) or were pre-treated with NAC before 6-AN treatment (right panels) and total protein extracts were analyzed by immunoblot with anti-pAMPKa(T172) and anti-AMPKa antibodies. Histograms in E and F report the densitometry analysis of the pAMPKa/AMPKa total. Average from at least three independent experiments 6 SD were plotted. doi:10.1371/journal.pone.0037526.g004 PI3K/GSK3b signaling in protecting and selecting cells during GD.
To directly link the MnSOD expression with resistance to GD, we generated wild type HME cell lines stably expressing the antioxidant MnSOD enzyme. Upregulation of MnSOD expression was sufficient to protect the cells from GD-induced cell death ( Figure 9B ). These results indicate that the increased MnSOD expression is an important component of oncogene-induced resistance to GD in cells carrying the delE746-A750 EGFR or E545K PIK3CA cancer alleles. All together, these data show that the oncogenic inactivation of GSK3b by the delE746-A750 EGFR or E545K PIK3CA cancer proteins significantly increases nuclear b-catenin pool in response to GD and enhances b-catenin-and FOXO4-dependent expression of genes involved in antioxidant stress response.
Discussion

An essential antioxidant role of glucose in mammary epithelial cells
In mammary epithelial cells the metabolic checkpoint for glucose concentration is based on ROS homeostasis. GD induces a significant reduction of the GSH/GSSG ratio, a severe oxidative stress and, ultimately, cell death. GSH level is controlled by PPP and depends on activation of NADPH oxidase and SOD. Activation of G6PDH and glutathione peroxidase in combination with NADPH oxidase and SOD maintains stable GSH levels [28] . In the absence of glucose and under low ATP levels, this process is inefficient and the GSH/GSSG ratio decreases, leading to rise of ROS levels. ROS generated by GD induce the phosphorylation and activation of AMPKa. Similarly, 2-Deoxy-D-glucose, a nothydrolysable glucose analogue, stimulates AMPKa(T172) phosphorylation by a ROS-mediated mechanism (LC, unpublished data and [29] ). Thus, ROS generated by GD act as metabolic intermediates able to activate AMPK. HME cells expressing the PIK3CA mutants are resistant to GDgenerated oxidative stress and show reduced AMPK activation.
We have found that the resistance strategies involve, at least in part, the activation of antioxidant enzymes such as MnSOD and catalase. The upregulation of MnSOD is adaptive since it increases the ROS neutralization as well as the rate of GSH production [28] . High basal levels of MnSOD expression has been reported associated to invasive and highly aggressive breast cancer [30, 31] and this may indicate the high ability of tumor cell to adapt to nutrient deprivation. Since the EGFR and PIK3CA are among the most frequently activated oncogenes in cancer, we suggest that the specific anti-oxidant transcriptional program driven by these oncogenes protects and favours the selection of the cells carrying the mutated proteins. Our data offer a mechanistic explanation for the selection and the reproductive success of such cells under environmental metabolic stress. We suggest that MnSOD and catalase expression may represent a common antioxidant mechanism in pre-cancerous cells harbouring activating mutation of the EGFR-and PI3K-dependent pathways. The ability to tune metabolic enzymes and pathways to survive under nutrient stress may represent a relevant and common phenotype of cancer cells. In this framework, we believe that also the hypertrophy of the serine synthesis pathway in breast cancer cells [32, 33] reflects the ability of cancer cells to continuously adapt to different metabolic needs.
Oncogenes and glucose metabolism: not just a matter of addiction in tumor progression
Specific metabolic changes occur during tumor development and allow cellular adaptation to the unstable tumor microenvironment. One of the most prominent metabolic changes in cancer cells is the high glycolytic rate in the presence of oxygen, a phenomenon known as the Warburg effect [1, 34, 35] . As consequences of the Warburg effect, cancer cells show increased glucose needs and higher sensitivity to glucose deprivation compared to normal cells, a phenomenon known as glucose addiction [35, 36] . In cancer cells, the expression of constitutive active AKT [37] , [38] , KRAS [3, 39, 40] or the activation of the mTOR pathway [14, 41] has been associated with an increased Warburg effect and higher sensitivity to glucose deprivation. Here, we demonstrate that in not-transformed mammary epithelial cells GD elicits cell death and that the expression of oncogenic EGFR and PIK3CA confers resistance rather than sensitivity to glucose deprivation. Moreover, we did not observe a significant increase of the glycolytic index in oncogenes-carrying clones compared to wild type HME (data not shown). This apparent contradiction might be explained by different experimental and biological conditions: i) the use of a constitutive membrane-bound AKT mutant [38] , [37] compared to the E545K PIK3CA and the delE746-A750 EGFR oncogenes; ii) the endogenous expression levels of the oncogenic allele in the knock-in models compared with the constitutive transgenic overexpression; iii) tissue-specific metabolic effects of each cancer mutations; iv) the use of pre-cancerous cells instead of transformed cancer cells that could, indeed, carry on additional mutations and whose combination could generate more complex metabolic phenotypes.
The observed oncogene-induced resistance to glucose deprivation in epithelial cells indicates that, during neoplastic progression, cancer cells may display a variable degree of glucose addiction, depending on the tumor stage: advanced tumors may show an increased glycolytic rate and glucose addiction as adaptive strategies that support acidosis, hypoxic growth and invasion. We suggest that pre-cancerous cells have an opposite strategy, since glucose addiction represents a strong metabolic Achilles' heel that limits the progression of cells carrying a functional AMPK, which represents an important metabolic checkpoint controlling cell fate under glucose deprivation [14] . In this perspective, glucose availability represents an intrinsic barrier that restricts aberrant proliferation of mammary cells. Oncogenic activation of EGFR or PI3K pathways selects and drives cellular clones able to surmount such metabolic barriers and to survive under suboptimal microenvironment conditions.
Enhanced nuclear b-catenin and FOXO4 signalling by oncogenic EGFR and PIK3CA
We have documented a positive feedback between the oncogenic EGFR and PI3K pathways with the FOXO4 and bcatenin signals in response to glucose deprivation. The role of FOXO proteins as tumor suppressors has been largely recognized and has been associated with their ability to promote cell cycle arrest [42] . Here, we propose that FOXO4, specifically activated by b-catenin, promotes cell resistance to oxidative metabolic stress and survival of oncogenes-carrying cells. This dual function of FOXOs may depend on a complex code of post-translational modifications and interacting co-activators that differentially control FOXOs functions under different conditions and in a tissue specific manner [42, 43] . There is evidence indicating an evolutionary conserved interaction between FOXO4 and bcatenin induced by starvation and enhanced by oxidative stress that drives the expression of antioxidant enzymes, such as MnSOD [26] . Along with these observations, our findings support the conclusion that b-catenin is a transcriptional co-activator that switches on FOXO target genes under nutrient stress and promotes cell survival.
We show that somatic mutations frequently observed in breast cancer lead to b-catenin activation: this observation strengthens emerging data outlining the relevance of the b-catenin activation in breast cancer [44, 45] and the crosstalk between EGFR and WNT signals in breast cancer development [46] . One mechanism, Figure 6 . Total glycogen content in oncogene-expressing HME cells after glucose deprivation. Total glycogen content after GD in wild type HME cells and isogenic clones carrying delE746-A750 EGFR, E545K PIK3CA or G13D KRAS cancer alleles. At the indicated time, cells were harvested and total glycogen content was analyzed. Results (average of three independent experiments 6 SD) are expressed as glycogen content normalized for protein mass. WT: wild type HME cells; PIK3CA_cnt and EGFR_cnt are HME control cells carrying the wild type alleles (see text for details). doi:10.1371/journal.pone.0037526.g006 EGFR or E545K PIK3CA cancer alleles were glucose starved for 5 hours and equal amounts of nuclear protein extracts were assayed by immunoblot as indicated. MCM7 antibody recognizes the nuclear minichromosome maintenance protein 7 and is here used as loading control. Graphs report the densitometry analysis of indicated protein/MCM7 signals ratio. Results report the average of three independent experiments 6 SD (t-test, **p,0.01; *p,0.05). (E) Intracellular localization of active b-catenin (ABC) after GD exposure. Wild type HME or isogenic cells carrying the delE746-A750 EGFR or the
E545K
PIK3CA cancer alleles were glucose-starved for 5 hours. Cell were fixed and stained with a specific anti active, not phosphorylated b-catenin antibody (Red) and DAPI (Blue) for the nuclear staining and analyzed by fluorescence microscopy. at least, involves the regulation of GSK3b, a key kinase controlling b-catenin stability. We propose that the GSK3b, b-catenin and MnSOD axis represents a potential target to lower the resistance to oxidative stress of tumor harboring oncogenic EGFR and PI3KCA.
Materials and Methods
Plasmids
Flag-b-catenin, pMT2-HA-FOXO4, pSOD-luc(23340+1) and the pSODmut-luc carrying point mutations in two FOXO binding sites were a generous gift from Dr B.M. Burgering (University Figure 9 . The GSK3b/b-catenin/MnSOD axis promotes resistance to GD-induced cell death. (A) Wild type HME cells were cotransfected with equal amounts of the indicated expression vectors. 24 hours after transfection, cells were glucose-starved for 48 hours and the percentage of dead cells was quantified by FACS analysis of propidium iodide positive cells. Graphs report the average derived from three independent experiments 6 SD (t-test, **p,0.01). The inset shows an anti-HA immunoblot of total protein extracts from cells transfected with the HA-GSK3b or HAGSK3b(K85R) vectors and used for the GD experiments. b-actin was used as loading control. (B) Wild type HME cells stably transfected with an empty vector (pcDNA#1 and pcDNA#2) or with an expression vector for MnSOD (MnSOD#1 and MnSOD#2) were exposed to GD for 60 hours and the percentage of dead cells were quantified by FACS analysis of propidium iodide positive cells. At least three independent empty vector-or MnSODtransfected clones were analyzed and gave similar results. The inset represents an immunoblot analysis showing the expression of MnSOD in total protein extracts from two representative clones used for the experiments. b-actin was used as loading control. Graphs report the average derived from three independent experiments 6 SD (t-test, **p,0.01 or ***p,0.001, empty vector Vs MnSOD). doi:10.1371/journal.pone.0037526.g009
Medical center, Utrecht, The Netherlands) and have been described elsewhere [24, 26] . CMV-Renilla luciferase was purchased from Promega. The pCDNA-MnSOD has been previously described [47] . Expression plasmids for wild type GSK3b and dominant-negative GSK3b(K85A) were purchased from Addgene.
Cell viability
Cell viability was determined by flow cytometry using propidium iodide (PI) staining. Briefly, after the specific treatments, detached and attached cells were collected, washed twice with PBS 16 and stained with propidium iodide; PI positive cells, e.g. death cells, were detected by flow cytometry with a FACSCalibur (Becton Dickinson) and analyzed by using the CellQuest software (Becton Dickinson).
ATP quantification
Cells were counted and plated in a 96-well plate in quadruplicates at the density of 3000 cells/well. After 48 hours, cells were glucose-starved and harvested at different time points. ATP assay was carried out using the ATPlite assay (Perkin Elmer) according to the manufacturer's instructions. A parallel experiment was performed to determine the cell number by nuclei counting after staining with 1 mg/ml Hoechst 33342. Nuclei were detected by florescence microscopy with a BD pathway HT bioimager with the AttoVision Acquisition Software Module and quantified by using the BD Date Image Explorer Software.
GSH/GSSG measurement
Reduced and oxidized Glutathione ratio was measured by using the GSH/GSSG-Glo assay kit (Promega) according to the manufacturer's protocol.
Quantitative Real-Time PCR Total RNA extraction was done using Tryzol (Invitrogen) according to the manufacturer's instructions. Total RNA was then reverse-transcribed into cDNA by using M-MLV Reverse Transcriptase (Gibco BRL) with oligo random hexamers. The cDNA was subjected to quantitative PCR analysis by using Light Cycler (Applied Biosystem) with SYBR Green PCR Master MIX Kit (Applied Biosystem). The primers sequences for the PCR analysis are available on request.
Statistical analysis
Data are presented as mean 6 standard deviation (SD). Statistical significance was analyzed by using, where appropriate, a two-tailed Student's t-test. P values less or equal than 0.05 were considered statistically significant.
Additional experimental procedures (materials and reagents, cell lines, cell culture and transfection, protein extracts, western blot analysis, glycogen measurement, luciferase reporter assay and immunoflorescence analysis) are provided as Methods S1. Figure S1 The insertion of oncogenic alleles by homologous recombination (knock-in) effectively and specifically affects the downstream signaling pathways in mammary epithelial cells. Wild type HME or isogenic cells carrying delE746-A750 EGFR or
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PI3KCA or G13D KRAS cancer mutations were treated with the indicated serum concentrations for 16 hours. Equal amounts of total protein extracts were analyzed by immunoblot with the indicated antibodies. ERK1/2 indicates the p42/p44 proteins; pERK1/2 indicates the Thr202 and Tyr204 phosphorylated residues of ERK1/2. pMEK1/2 indicates the phosphorylated residues at Ser217 and Ser221 of MEK1/2. Data are representative of three independent experiments that gave similar results. (TIF) Figure S2 HME clones carrying the delE746-A750 EGFR or the E545K PIK3CA allele are resistant to GD-induced cell death. Additional HME clones carrying oncogenic mutationsindependently generated from clones presented in Figure 1 -were glucose starved for 48 hours. The percentage of dead cells was quantified by FACS analysis of propidium iodide positive cells. Results report the data derived on the average from four independent experiments 6 SD. (TIF) Figure S3 Phosphorylation of AMPKa(T172) in wild type HME cells and in isogenic control knock-in cells. (A) Additional HME clones carrying oncogenic mutations -independently generated from clones presented in Figure 1 -were glucose starved for 10 hours and equal amount of total protein extracts were assayed by immunoblot with the indicated antibodies. (B) Wild type HME and isogenic knock-in clones generated by homologous recombination of the wild type EGFR or PIK3CA alleles were treated and analyzed as in (A). The levels of pAKT(S437) on the same protein extracts are also reported showing that the activation of the PI3K-dependent pathways is comparable in all three clones. (TIF) Figure S4 Upregulation of MnSOD by EGFR or PIK3CA cancer alleles in response to GD. Wild type HME and isogenic cells carrying delE746-A750 EGFR or E545K PIK3CA alleles were glucose starved for the indicated hours. Total proteins were extracted and analyzed by immunoblot with the indicated antibodies. The graph reports the densitometry analysis of the MnSOD/TOM1 signals and the average from three independent experiments 6 SD. (TIF) Methods S1
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